MED
NYSE · Consumer products
Medifast Inc
$11.36
+0.53 (+4.89%)
Income Statement
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 15.83M | 15.63M | 13.56M |
| Net Income | 2.79M | 2.36M | 2.26M |
| EPS | — | — | — |
| Profit Margin | 17.6% | 15.1% | 16.7% |
| Rev Growth | +23.6% | +0.8% | +24.6% |
Balance Sheet
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Total Debt | 57.19M | 67.55M | 61.71M |
| Total Equity | 100.93M | 104.54M | 106.99M |
| D/E Ratio | 0.57 | 0.65 | 0.58 |
Cash Flow
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| EBITDA | 4.82M | 4.67M | 3.57M |
| Free Cash Flow | 2.73M | 2.91M | 2.77M |